HealthEquity, Inc. (NASDAQ:HQY) Stock Position Decreased by Victory Capital Management Inc.

Victory Capital Management Inc. decreased its position in HealthEquity, Inc. (NASDAQ:HQY) by 19.1% in the 3rd quarter, Holdings Channel.com reports. The firm owned 267,597 shares of the company’s stock after selling 63,091 shares during the period. Victory Capital Management Inc.’s holdings in HealthEquity were worth $21,903,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. GSA Capital Partners LLP bought a new position in HealthEquity in the 3rd quarter worth about $638,000. GDS Wealth Management bought a new position in HealthEquity in the 3rd quarter worth about $2,344,000. Los Angeles Capital Management LLC grew its position in HealthEquity by 92.3% in the 3rd quarter. Los Angeles Capital Management LLC now owns 55,597 shares of the company’s stock worth $4,551,000 after purchasing an additional 26,690 shares during the last quarter. Covestor Ltd grew its position in HealthEquity by 27.4% in the 3rd quarter. Covestor Ltd now owns 1,524 shares of the company’s stock worth $125,000 after purchasing an additional 328 shares during the last quarter. Finally, Assetmark Inc. grew its position in HealthEquity by 457.5% in the 3rd quarter. Assetmark Inc. now owns 4,544 shares of the company’s stock worth $372,000 after purchasing an additional 3,729 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Insider Buying and Selling at HealthEquity

In other news, Director Frank Corvino sold 1,039 shares of the stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now owns 3,784 shares in the company, valued at $363,642.40. This represents a 21.54 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now owns 54,719 shares in the company, valued at approximately $4,540,582.62. This trade represents a 13.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 10,536 shares of company stock worth $884,517. 2.20% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

HQY has been the subject of several recent analyst reports. JMP Securities restated a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a report on Wednesday, September 4th. Bank of America increased their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. Barrington Research reiterated an “outperform” rating and issued a $105.00 price objective on shares of HealthEquity in a report on Friday, September 20th. Finally, BTIG Research increased their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, November 14th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and a consensus target price of $107.23.

HealthEquity Stock Up 3.5 %

Shares of NASDAQ:HQY opened at $102.40 on Tuesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. The company has a market cap of $8.94 billion, a PE ratio of 85.33, a price-to-earnings-growth ratio of 1.55 and a beta of 0.52. HealthEquity, Inc. has a 52 week low of $62.10 and a 52 week high of $103.12. The firm has a 50 day simple moving average of $85.54 and a 200 day simple moving average of $81.25.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.50 by $0.16. The business had revenue of $299.93 million during the quarter, compared to the consensus estimate of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. As a group, research analysts expect that HealthEquity, Inc. will post 2.27 earnings per share for the current year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.